senate Bill S4277A

2019-2020 Legislative Session

Requires health practitioners to discuss with patients the risks associated with certain pain medications before prescribing such medications

download bill text pdf

Sponsored By

Archive: Last Bill Status - In Senate Committee Health Committee


  • Introduced
  • In Committee
  • On Floor Calendar
    • Passed Senate
    • Passed Assembly
  • Delivered to Governor
  • Signed/Vetoed by Governor

Your Voice

do you support this bill?

Please enter your contact information

Home address is used to determine the senate district in which you reside. Your support or opposition to this bill is then shared immediately with the senator who represents you.

Optional services from the NY State Senate:

Create an account. An account allows you to officially support or oppose key legislation, sign petitions with a single click, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.

Include a custom message for your Senator? (Optional)

Enter a message to your senator. Many New Yorkers use this to share the reasoning behind their support or opposition to the bill. Others might share a personal anecdote about how the bill would affect them or people they care about.

Actions

view actions (12)
Assembly Actions - Lowercase
Senate Actions - UPPERCASE
Jan 08, 2020 referred to health
returned to senate
died in assembly
Jun 12, 2019 referred to health
delivered to assembly
passed senate
May 06, 2019 advanced to third reading
May 01, 2019 2nd report cal.
Apr 30, 2019 1st report cal.538
Apr 12, 2019 print number 4277a
Apr 12, 2019 amend (t) and recommit to health
Mar 06, 2019 referred to health

S4277 - Details

See Assembly Version of this Bill:
A7285
Current Committee:
Senate Health
Law Section:
Public Health Law
Laws Affected:
Add §§3309-b & 3309-c, Pub Health L
Versions Introduced in Other Legislative Sessions:
2021-2022: S6043, A3405
2023-2024: S3521, A1227

S4277 - Summary

Requires health practitioners to discuss with patients the risks associated with certain pain medications before prescribing such medications; requires that for the first opioid analgesic prescription of a calendar year the prescribing physician shall counsel the patient on the risks of overdose.

S4277 - Sponsor Memo

S4277 - Bill Text download pdf


                    S T A T E   O F   N E W   Y O R K
________________________________________________________________________

                                  4277

                       2019-2020 Regular Sessions

                            I N  S E N A T E

                              March 6, 2019
                               ___________

Introduced  by Sen. HARCKHAM -- read twice and ordered printed, and when
  printed to be committed to the Committee on Health

AN ACT to amend the public health law, in relation to  requiring  health
  practitioners  to  discuss  with  patients  the  risks associated with
  certain pain medications before prescribing such medications

  THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND  ASSEM-
BLY, DO ENACT AS FOLLOWS:

  Section  1.  The  public health law is amended by adding a new section
3309-b to read as follows:
  § 3309-B. PRACTITIONER AND PATIENT DISCUSSIONS; OPIOID  PRESCRIPTIONS.
1. PRIOR TO ISSUING THE INITIAL PRESCRIPTION OF A SCHEDULE II CONTROLLED
SUBSTANCE  FOR THE TREATMENT OF PAIN OR ANY OTHER OPIOID DRUG WHICH IS A
PRESCRIPTION DRUG FOR ACUTE OR CHRONIC PAIN AND AGAIN PRIOR  TO  ISSUING
THE  THIRD PRESCRIPTION OF THE COURSE OF TREATMENT, A PRACTITIONER SHALL
DISCUSS WITH THE PATIENT, OR THE PATIENT'S PARENT  OR  GUARDIAN  IF  THE
PATIENT  IS UNDER EIGHTEEN YEARS OF AGE AND IS NOT AN EMANCIPATED MINOR,
THE RISKS ASSOCIATED WITH THE DRUGS BEING PRESCRIBED, INCLUDING BUT  NOT
LIMITED TO:
  (A)  THE  RISKS OF ADDICTION AND OVERDOSE ASSOCIATED WITH OPIOID DRUGS
AND THE DANGERS OF TAKING OPIOID DRUGS WITH ALCOHOL, BENZODIAZEPINES AND
OTHER CENTRAL NERVOUS SYSTEM DEPRESSANTS;
  (B) THE REASONS WHY THE PRESCRIPTION IS NECESSARY;
  (C) ALTERNATIVE TREATMENTS THAT MAY BE AVAILABLE; AND
  (D) THE RISKS ASSOCIATED WITH THE USE OF THE DRUGS  BEING  PRESCRIBED,
SPECIFICALLY  THAT  OPIOIDS  ARE  HIGHLY  ADDICTIVE,  EVEN WHEN TAKEN AS
PRESCRIBED, THAT THERE IS A RISK OF DEVELOPING A PHYSICAL OR  PSYCHOLOG-
ICAL  DEPENDENCE  ON  THE  CONTROLLED  SUBSTANCE,  AND THAT THE RISKS OF
TAKING MORE OPIOIDS THAN PRESCRIBED, OR  MIXING  SEDATIVES,  BENZODIAZE-
PINES   OR  ALCOHOL  WITH  OPIOIDS,  CAN  RESULT  IN  FATAL  RESPIRATORY
DEPRESSION.

 EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                      [ ] is old law to be omitted.
                                                           LBD10262-01-9

Co-Sponsors

view additional co-sponsors

S4277A (ACTIVE) - Details

See Assembly Version of this Bill:
A7285
Current Committee:
Senate Health
Law Section:
Public Health Law
Laws Affected:
Add §§3309-b & 3309-c, Pub Health L
Versions Introduced in Other Legislative Sessions:
2021-2022: S6043, A3405
2023-2024: S3521, A1227

S4277A (ACTIVE) - Summary

Requires health practitioners to discuss with patients the risks associated with certain pain medications before prescribing such medications; requires that for the first opioid analgesic prescription of a calendar year the prescribing physician shall counsel the patient on the risks of overdose.

S4277A (ACTIVE) - Sponsor Memo

S4277A (ACTIVE) - Bill Text download pdf


                    S T A T E   O F   N E W   Y O R K
________________________________________________________________________

                                 4277--A

                       2019-2020 Regular Sessions

                            I N  S E N A T E

                              March 6, 2019
                               ___________

Introduced  by Sen. HARCKHAM -- read twice and ordered printed, and when
  printed to be committed  to  the  Committee  on  Health  --  committee
  discharged, bill amended, ordered reprinted as amended and recommitted
  to said committee

AN  ACT  to amend the public health law, in relation to requiring health
  practitioners to discuss  with  patients  the  risks  associated  with
  certain  pain  medications before prescribing such medications; and in
  relation to opioid analgesic prescriptions

  THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND  ASSEM-
BLY, DO ENACT AS FOLLOWS:

  Section  1.  The  public health law is amended by adding a new section
3309-b to read as follows:
  § 3309-B. PRACTITIONER AND PATIENT DISCUSSIONS; OPIOID  PRESCRIPTIONS.
1. PRIOR TO ISSUING THE INITIAL PRESCRIPTION OF A SCHEDULE II CONTROLLED
SUBSTANCE  FOR THE TREATMENT OF PAIN OR ANY OTHER OPIOID DRUG WHICH IS A
PRESCRIPTION DRUG FOR ACUTE OR CHRONIC PAIN AND AGAIN PRIOR  TO  ISSUING
THE  THIRD PRESCRIPTION OF THE COURSE OF TREATMENT, A PRACTITIONER SHALL
DISCUSS WITH THE PATIENT, OR THE PATIENT'S PARENT  OR  GUARDIAN  IF  THE
PATIENT  IS UNDER EIGHTEEN YEARS OF AGE AND IS NOT AN EMANCIPATED MINOR,
THE RISKS ASSOCIATED WITH THE DRUGS BEING PRESCRIBED, INCLUDING BUT  NOT
LIMITED TO:
  (A)  THE  RISKS OF ADDICTION AND OVERDOSE ASSOCIATED WITH OPIOID DRUGS
AND THE DANGERS OF TAKING OPIOID DRUGS WITH ALCOHOL, BENZODIAZEPINES AND
OTHER CENTRAL NERVOUS SYSTEM DEPRESSANTS;
  (B) THE REASONS WHY THE PRESCRIPTION IS NECESSARY;
  (C) ALTERNATIVE TREATMENTS THAT MAY BE AVAILABLE; AND
  (D) THE RISKS ASSOCIATED WITH THE USE OF THE DRUGS  BEING  PRESCRIBED,
SPECIFICALLY  THAT  OPIOIDS  ARE  HIGHLY  ADDICTIVE,  EVEN WHEN TAKEN AS
PRESCRIBED, THAT THERE IS A RISK OF DEVELOPING A PHYSICAL OR  PSYCHOLOG-
ICAL  DEPENDENCE  ON  THE  CONTROLLED  SUBSTANCE,  AND THAT THE RISKS OF
TAKING MORE OPIOIDS THAN PRESCRIBED, OR  MIXING  SEDATIVES,  BENZODIAZE-

 EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                      [ ] is old law to be omitted.

Comments

Open Legislation is a forum for New York State legislation. All comments are subject to review and community moderation is encouraged.

Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity, hate or toxic speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Attempts to intimidate and silence contributors or deliberately deceive the public, including excessive or extraneous posting/posts, or coordinated activity, are prohibited and may result in the temporary or permanent banning of the user. Comment moderation is generally performed Monday through Friday. By contributing or voting you agree to the Terms of Participation and verify you are over 13.